Boothbay Fund Management, LLC Atreca, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $73,852 - $238,529	-45,871 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.87 - $6.29 $131,649 - $288,528	45,871 New	45,871 $139,000
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $182,470 - $337,068	-37,163 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.82 - $13.8 $290,614 - $512,849	37,163 New	37,163 $317,000
Q3 2020 Nov 16, 2020	SELL	$12.67 - $23.19 $173,350 - $317,285	-13,682 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.52 - $23.45 $171,298 - $320,842	13,682 New	13,682 $291,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.